Abstract.-Purpose. This study was undertaken to determine the value of using dual-time point 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) imaging to distinguish malignant from benign pulmonary lesions after lesion detection by conventional computed tomography chest imaging.
INTRODUCTION
Pulmonary nodules affect 0.1 % to 0.2 % of the general adult population 1 . In the United States, approximately 130,000 new pulmonary nodules are diagnosed each year 2 , and with the increasing popularity of lung cancer screening with helical and multislice computed tomography (CT), the number will likely rise. Approximately 20 % to 50 % of these nodules are malignant, varying according to factors such as patient age, smoking history, or previous malignancy.
Conventional evaluation of pulmonary nodules has limitations. Most pulmonary nodules remain indeterminate on repeated CT scans. Because a watch-andwait policy is not advocated unless the likelihood of malignancy is less than 10 %, an invasive procedure to obtain samples for histopathologic examination is the main evaluation method.
Bronchoscopy, including bronchial washings, has a sensitivity of 20 % to 80 %, depending on the size of the nodule, its proximity to the bronchial tree, and the prevalence of cancer in the study population. For nodules less than 1.5 cm in diameter, the sensitivity drops to 10 %; therefore, negative findings on bronchoscopy do not exclude malignancy.
Another nonsurgical approach to diagnosis is transthoracic fine needle aspiration biopsy, with most studies reporting sensitivities of 75 % to 86 % 3, 4 . Even for lesions that are less than 2 cm in diameter, transthoracic fine needle aspiration biopsy has a sensitivity of no more than 60 % for detecting malignant processes, but the false-negative rate is 3 % to 29 %. In addition, complication rates are higher for this technique than are those for bronchoscopy, with an incidence of pneumothorax of up to 30 %, requiring chest tube placement in up to 26 % of patients in some series 5 . A relatively new noninvasive procedure that has widespread applications for the evaluation of pulmonary nodules is 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) imaging. Kubota et al 6 first described the value of this technique for characterizing pulmonary nodules and differentiating between benign and malignant lesions. Since then, other investigators have reported the utility of FDG-PET for imaging pulmonary nodules. In a meta-analysis, the sensitivity for identifying a malignant process in the lungs with FDG-PET were reported to be 96.8 % and its specificity 77. 8 % 7 .
Standardized uptake values (SUVs) above 2.5 are used as a semiquantitative index to aid in differentiating benign and malignant pulmonary nodules with PET imaging. However, the use of SUVs has limitations because some malignant lesions such as bronchoalveolar cell carcinoma 8 and bronchial carcinoid are known to poorly concentrate FDG. In small (subcentimeter) lesions, FDG uptake is underestimated because of partial volume effects. Moreover, inflammatory and infectious lesions may demonstrate increased and sometimes prominent FDG uptake above the cut-off SUV value of 2.5, limiting the specificity of the method.
Hustinx et al 9 reported the results of dual-timepoint FDG-PET imaging in the evaluation of 18 patients with head and neck cancer and 9 patients with inflammatory lesions. They found that in the tumors, there was a mean 12 % increase in FDG uptake between the first and second scans, but in the inflammatory lesions, FDG uptake was stable over time or declined slightly. Since then, several other investigators [10] [11] [12] [13] [14] have reported similar results with dual-time point FDG-PET imaging.
The purpose of this prospective study was to determine the value of dual-time-point imaging in distinguishing malignant from benign pulmonary lesions in patients referred for FDG-PET imaging after lesion detection by conventional CT chest imaging.
PATIENTS AND METHODS

Patient population
Patients were referred to us for FDG-PET imaging for characterization and differentiation of suspicious pulmonary densities found on conventional CT scans of the chest. All patients who presented to our department between December 2001 and December 2003 with pulmonary densities of at least 1 cm in diameter and who had histopathologically characterized lesions were included in the study. Eighty-three patients (46 women and 37 men; mean age, 69 ± 11 years; range, 38-88 years) were included in the analysis.
Imaging protocol
Details of the study were explained to patients by a physician, and informed consent was obtained. The study was approved by the institutional IRB. Patients underwent imaging twice on the same day using a dual-detector gamma camera operating in coinci-dence mode (Solus, Molecular Coincidence Imaging, ADAC Laboratories, Milpitas, California) after a single injection of 185 MBq (5 mCi) of 18 F-FDG. Initially, a whole-body PET scan ("early" scan) was acquired at 57 ± 12 min after intravenous injection of 18 F-FDG, imaging the neck, chest, abdomen, and upper third of the pelvis.
The second PET scan ("late" scan) was performed at 3 h and 17 min ± 13 min after the initial injection, imaging the lower neck, chest and upper abdomen. All patients fasted a minimum of 6 h prior to the injection of 18F-FDG and during the interval between early and late scans.
Coincidence-PET imaging
The early PET scan consisted of 2 bed positions, and the late PET scan, only 1 bed position. The axial field of view was 38 cm when 1 bed position was used and 57 cm with 2 bed positions. All patients were imaged for 32 stops through a rotation of 180°p er detector at 40 s/frame for the early scan. To compensate for decay of 18 F-FDG, the late scan was acquired at 60 s/frame. Data were acquired in 3-dimensional mode, and decay correction was performed during the acquisition. Images were corrected for photon attenuation with a transmission scan using 137-Cs point sources. The total acquisition time of emission and transmission scans was approximately 30 min per bed position.
Energy windows were set at 511 keV/30 % for the 18F-FDG photopeak, 310 KeV/30 % for the Compton events in the NaI crystal, and 662 keV/30 % for the 137 Cs photopeak. The coincidence mode of acquisition used all photopeak-photopeak events and photopeak-Compton scatter events. The detectors provided a timing resolution of 6 ns, and a 15-ns timing window was used to acquire coincidence events. The spatial resolution in axial and transaxial directions (full-width half maximum) for this type of scanner has been documented to be 0.5 cm by National Electrical Manufacturers Association standards 15 . All data were rebinned using single-slice rebinning and reconstructed using an ordered subset expectation maximization iterative algorithm provided by the scanner's manufacturer.
Visual assessment
All images were read independently by 2 nuclear medicine physicians who had knowledge of the location of the pulmonary nodule but not of the final diagnosis. For both early and late PET scans from each patient, readers were asked to classify the lesions as either malignant or benign (dichotomous score) on the basis of their visual perception of the greater local tracer uptake by the lung lesion compared with the uptake by the mediastinum. The likelihood of malignancy of each lesion was also graded on a scale of 1 (definitively benign) to 5 (definitively malignant) on the paired early and late images using the same criteria of relative tracer uptake.
In addition, the early and late scans were compared together, and readers judged whether uptake of FDG by the lesions increased, decreased, or remained stable over time. Finally, visual readings were compared between the 2 observers.
Quantitative analysis
Quantitative analysis of the lesions was performed using the attenuation-corrected coronal images. For all patients, square regions of interest (ROIs) of the same size (5 pixels × 5 pixels) were drawn manually by an observer over perceived lung lesions. Mean FDG counts per pixel were measured within each ROI. For each patient, regions of identical size were also drawn over the contralateral lung, which served as the control region. The same locations were used for target and background ROIs for early and late scans. For lesions with no uptake of FDG, an ROI was drawn in the area where the lesion was supposed to be located on the basis of the anatomic information obtained from the CT scan. Tumor target-to-background (T:B) ratios were generated by dividing the mean ROI counts of the lesions by the mean ROI counts of the contralateral lung background areas. The percentage change of the T:B ratios was defined as 100 % × (late T:B -early T:B)/early T:B.
Subanalysis by physical lesion size
To facilitate analysis by lesion size, no lesion was excluded because of size. By CT, the median lesion size was 2.5 cm. Subjects were divided into those with lesions smaller than 2.5 cm versus those with larger lesions, including both benign and malignant lesions. Accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated separately for the T:B quanti-tative analysis and dichotomous visual scores, for each of these two groups.
Statistical analysis
All values are reported as means ± 1 standard deviation. Analysis of the interpretations of the early and late PET scans by each reader was performed using biopsy results as the standard of truth. The ability of T:B ratios to discriminate malignant from benign lesions was assessed by optimizing the accuracy of lesion characterization on imaging versus that on histopathologic evaluation. The degree of agreement between readers was assessed using Kendall statistics, and agreement between observers of 5-pointscale readings was assessed by Spearman's rank correlation. Receiver operating characteristic (ROC) curves were generated for the readings from the scores assigned by the visual estimation of FDG uptake by pulmonary lesions. The visual readings from the 2 physicians were also combined into a single set of readings, for a total of 166 visual judgments (83 readings per observer), and compared with the biopsy results for the 83 patients.
Accuracy, sensitivity, specificity, PPV, and NPV were calculated separately for the T:B quantitative analysis, dichotomous visual scores, and 5-point-scale visual scores. McNemar's test was used to compare the pairs of tests of dichotomous readings. An analysis of proportions was used to compare the results among all discrimination methods in this investigation and to compare this study's results with those of previous investigators. For all tests, a probability (p) value of < 0.05 was defined as statistically significant.
RESULTS
Characterization of patients' pulmonary lesions
Eighty-three lesions (1 lesion per patient) were evaluated in this study. Sixty one lesions (74 %) were non-small cell lung cancer, and 10 (12 %) were other primary tumors or metastases (table 1) . Twelve lesions (14 %) were benign, of which 7 (8 %) were sites of granulomatous disease, including tuberculosis (caseating granuloma), and five (6 %) were nongranulomatous lesions.
Dichotomous visual readings
Agreement was excellent between the 2 readers for dichotomous readings of early scans (kappa = 0.89, p < 0.0001), late scans (kappa = 0.89, p < 0.0001), and changes between scans (kappa = 0.79, p < 0.0001). Because dichotomous readings for the 2 observers were similar for accuracy, sensitivity, specificity, PPV, and NPV, with no statistically significant differences between them, for subsequent analyses of dichotomous interpretation, their readings were combined into a single set, for a total of 166 visual judgments (83 readings per observer), and compared with the biopsy results for the 83 patients.
The accuracy was significantly lower for the early scans versus the late scans (72 % versus 78 %, p < 0.02). Sensitivity values were also significantly lower for the early scans versus the late scans (74 % versus 85 %, p < 0.001) and for changes in intensity (74 % versus 82 %, p < 0.01). However, the specificity values were not significantly different (table 2) .
For the benign lesions, the visual interpretations were correct in 50 % of the readings of the early scans scan interpretation for nongranulomatous lesions, being correct 60 % of the time (6 of 10 readings for 5 lesions) on both occasions. However, for granulomatous lesions, the interpretation was correct in 57 % of the readings (8 of 14 readings for 7 lesions) for the early scans, dropping to 29 % (4 of 14 readings for 7 lesions) for the late scans.
ROC analysis of visual readings
Agreement was strong between the readings of the 2 observers on a 5-point scale for the early scans As with dichotomous readings, because there were no statistically significant differences between the ROC analyses of the 2 observers, for subsequent ROC analyses, the readings of the 2 observers were combined into a single set of readings, for a total of 166 visual judgments (83 readings per observer), and compared with the biopsy results for the 83 patients. Figure 1 shows the ROC curves for the combined readings of the 2 observers for early scans, late scans, and changes between scans. There were no significant differences between early scans, late scans, or time changes between scans for ROC determinations of accuracy (table 3) .
Quantitative analysis of T:B ratios
For the 12 benign lesions, early versus late T:B ratios were not significantly different (2.6 ± 2.2 versus 3.1 ± 3.4). However, for the 71 malignant lesions, early versus late T:B ratios were significantly lower (5.1 ± 4.9 versus 8.2 ± 8.7, p = 0.01) (table 4). In addition, there were significantly different percent fig T:B ratios for early and late scans and for time changes between scans were analyzed for their ability to discriminate malignant from benign lesions. The T:B threshold values that maximized accuracy were 1.1 for early scans and independently determined to also be 1.1 for late scans. The threshold for the percentage change in T:B ratios with time was Ն + 10 %. Thus, tumor counts 10 % higher than background counts, whether for early or late scans, and for further increases with time of at least 10 % were all indicative of malignancy.
The accuracy of the use of T:B values to discriminate malignant from benign lesions was nearly identical for early, late, and time-difference values (83 %, 86 %, and 84 %, respectively), as was sensitivity (92 %, 95 %, and 87 %, respectively) (table 5). Specificity values were not statistically significantly higher for early scans, late scans, or percentage change between early and late scans (25 %, 33 %, and 66 %, respectively) (table 5) .
T:B time change criteria were correct in 57 % (4 of 7) of benign granulomatous lesions and 60 % (3 of 5) of benign nongranulomatous lesions.
There were no obvious distinguishing characteristics of the 9 malignant lesions incorrectly declared to be benign by T:B time change < 10 % criterion, as their size of 3.0 ± 3.5 cm (range, 0.8 cm to 12.0 cm) was not different from that of all other lesions. These mischaracterized lesions consisted of a variety of cell types (2 bronchoalveolar, 3 adenocarcinoma, 2 squamous cell, 1 spindle cell, and 1 carcinoid).
Subanalysis by physical lesion size
By CT, the mean lesion size was 3.3 ± 2.2 cm, and the median lesion size was 2.5 cm. Lesion sizes were not different for benign lesions (2.3 ± 1.1 cm; range, 1.6 cm to 4.8 cm) versus malignant lesions (3.4 ± 2.4 cm; range, 1 cm to 12 cm).Subjects were divided into those with lesions smaller than 2.5 cm (n = 43; size = 1.7 ± 0.5 cm) versus those with larger lesions (n = 40; size = 4.9 ± 2.2 cm), including both benign and malignant lesions.
For dichotomous visual analysis, larger lesions were detected more accurately and sensitively than smaller lesions for early scans (accuracy = 90 % versus 54 %, p < 0.0001; and sensitivity = 94 % versus 51 %, p = 0.03) and late scans (accuracy = 92 % versus 65 %, p = 0.0001; and sensitivity = 97 % versus 71 %, p < 0.0001) but not for changes between scans (table 6A) . For smaller lesions, percent change was more sensitive than readings of early scans (74 % versus 51 %, p < 0.01) but not otherwise (table 6A) .
By quantitative analysis, larger lesions were detected with higher sensitivity than smaller lesions for early scans only (100 % versus 84 %, p = 0.03) (table 6B) but were not different for late scans or changes between scans. By quantitative analysis, accuracy and specificity were not different for larger versus smaller lesions for any scans.
For larger lesions, linear regression analysis demonstrated statistically significant correlations between T:B ratios and lesion size for both early scans (r = 0.56, p = 0.0002) and late scans (r = 0.50, 
DISCUSSION
Delayed FDG-PET imaging is a technique that can facilitate the characterization of pulmonary lesions, especially when the size of the lesion is at the limit of resolution of the PET scanner or the malignancy shows poor FDG uptake. In our series, we achieved higher sensitivity and accuracy with the semiquantitative analysis of late images, with no statistically significant change in the specificity. Because, early FDG-PET imaging does not appear to provide better results or additional information than delayed imaging, it may be speared from the imaging protocol.
The usefulness of FDG-PET imaging in the evaluation of patients with pulmonary nodules is well documented in the scientific literature [16] [17] [18] ; pulmonary nodules are not only one of the first clinical applications of this imaging technique but also a major indication for PET imaging in most PET centers. Since the first prospective evaluation of PET by Kubota et al 6 , studies of more than 2,000 patients have provided favorable results, with sensitivities of 83 % to 100 % (overall sensitivity calculated from the pooled data of 95.9 %) and specificities of approximately 52 % to 100 % (overall specificity from the pooled data of 78.1 %) 19 . These data clearly show that FDG-PET is the most sensitive and specific imaging technique available today for the characterization of pulmonary nodules. While FDG-PET imaging has been increasingly used in patients with pulmonary nodules, we have gained more knowledge and a better understanding of the limitations of the technique. The clinical interpretation of PET scans by visual analysis and SUVs to determine the benign or malignant nature of pulmonary lesions is limited in small lesions (< 1 cm), in which partial volume effects will produce an underestimation of true FDG uptake 20 . In addition, it is well documented that several benign conditions, such as sarcoidosis, tuberculosis, histoplasmosis, and Wegener's granulomatosis 21 , can demonstrate increased FDG uptake above the accepted SUV cut-off value of 2.5 22 . Moreover, well-differentiated malignancies may show little if any increase in metabolic activity compared with surrounding normal tissues and constitute causes for false-negative readings. In particular, bronchoalveolar cell carcinoma, carcinoids, and well-differentiated adenocarcinomas have been shown to poorly concentrate FDG 23 . Therefore, investigators have researched additional techniques to further improve the noninvasive characterization of pulmonary nodules. The use of conventional SPECT imaging with 201-thallium has not provided an additional advantage over FDG-PET imaging 13 .
Benign lung lesions can demonstrate uptake of 201-thallium in an imaging modality that has inherently lower resolution than PET. Other PET tracers, such as the radiolabeled amino acid 11C-methionine, have been found to have similar sensitivity but less or similar specificity to FDG 6, 24 . Studies with tyrosine, another amino acid, labeled with either 11C or 18F as 18F-fluoro-methyltyrosine, have shown that the sensitivity is lower than FDG for the detection of malignant lesions 25 . None of these PET tracers . The results of the present investigation show that with dual-time point FDG-PET imaging of pulmonary lesions, there is an increase in sensitivity in the interpretation of early to late images ( fig. 5 ), varying slightly according to the method of analysis used. Using the combined visual dichotomous readings, the sensitivity improved from 74 % to 85 % (p < 0.05), and the accuracy improved from 72 % to 78 % (p < 0.05). However, there was a slight decrease in the specificity, from 58 % to 41 %, which nevertheless was not statistically significant. The results are similar for the semiquantitative analysis, in which there was an improvement in sensitivity from early to late imaging of 92 % to 95 % and in accuracy from 83 % to 86 %, respectively. It was interesting that there was a slight drop in the specificity from early to late imaging using the dichotomous interpretation (table 2), but this was not the case with the semiquantitative analysis, which increased minimally from early to late imaging and even more using the evaluation of time change in uptake, going from 25 % to 33 % and 66 %, respectively. Nevertheless, these differences were not statistically significant. These outcomes are similar to the ones obtained by Matthies et al 11 and Demura et al 13 . However, the specificity in our study is on the lower side of the published range, probably because of the limited number of benign pulmonary nodules included in our series (12 [14 %]), which limits an accurate estimation of the true-negative and false-positive rates. Nevertheless, all lesions in our study, either benign or malignant, had histopathologic confirmation.
The interpretation of the late images, either visually or semiquantitatively, provided higher sensitivity and accuracy than the early images, with no statistically significant change in the specificity. Therefore, it would be possible to spare the early image without affecting the sensitivity and accuracy of the study. Nevertheless, the semiquantitative analysis of T:B ratios above optimum thresholds of 10 % appears necessary to obtain better results.
One finding that is not surprising was that larger lesions are detected more accurately and with higher sensitivity than smaller lesions, either by visual dichotomy interpretation or by semiquantitative analysis (tables 6A and 6B). However, the improvement in accuracy and sensitivity with dual-time point imaging was seen only in smaller lesions.
Even though the total number of benign lesions (n = 12) was not very large, there was a tendency for better characterization of benign nongranulomatous lesions than benign granulomatous lesions, with visual analysis being correct in 60 % of cases for early and late imaging for the former and decreasing to 57 % and 29 %, respectively, for the latter. Similar findings have been seen by other investigators 9,12,13 , A B which is probably a reflection of different washout rates of these 2 lesion types. In fact, in our study, the percent change ratios of uptake from early to late PET imaging were not significantly different between malignant and benign granulomatous lesions; however, there was a statistically significant difference between malignant and benign nongranulomatous lesions (table 4) . The main limitation of our study is the rather small number of benign lesions included for analysis-12 of 83 lesions. A higher number of benign lesions would have been desirable to more accurately determine the true-negative and false-positive rates of the technique. However, the small number of patients was mainly because only lesions with histologic confirmation were included in the study. In addition, although our results are comparable to those of other investigators [9] [10] [11] [12] [13] , they probably could have been improved with the use of a dedicated PET scanner instead of a coincidence gamma camera.
CONCLUSIONS
Our results show that in malignant pulmonary lesions, there is a progressive, although variable, increase in FDG uptake over time. Increasing FDG uptake is a nonspecific finding, as some benign lesions also demonstrate increasing uptake. The use of delayed PET imaging with semiquantitative analysis improves the sensitivity and accuracy of the characterization of pulmonary lesions, with no statistically significant change in the specificity. Therefore, appears to be possible to avoid the early image without affecting the results of the study.
